China’s pharmaceutical giants have made out-licensing drugs a major part of their business development strategy as they transition from developing generics to innovative drugs
Sadaff Habib, an independent arbitrator based in Dubai, points out the major challenges in local arbitration and offers key tips for Chinese businesses
Governments adopting trace-and-track apps to prevent the spread of this coronavirus have raised questions about the ‘right balance’ between crisis response and privacy considerations